HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment and outcome of gastrointestinal bleeding due to peptic ulcers and erosions - (BLUE study).

AbstractOBJECTIVES:
Peptic ulcers and erosions are the most common causes of upper gastrointestinal bleeding. The aim of this study was to investigate the management and outcomes of these patients.
MATERIALS AND METHODS:
A total of 543 patients with endoscopically confirmed bleeding from peptic ulcers and erosions were included from March 2015 to December 2017. The patient characteristics, endoscopic findings, Forrest classification and endoscopic treatment were recorded. Moreover, the rebleeding rates, repeated endoscopies and transcatheter angiographic embolization and surgery incidences were registered. A follow-up endoscopy after discharge from the hospital was scheduled.
RESULTS:
Among the patients, high-risk stigmata ulcers were present in 36% (198/543) and low-risk stigmata ulcers and erosions in 60% (327/543) at first endoscopy. Endoscopic therapy was performed in 30% (165/543) of the patients, and hemostasis was achieved in 94% (155/165). The incidence of rebleeding was 9% (49/543) for the whole cohort and 14.8% (23/155) for those patients who had received successful endoscopic treatment. Moreover, rebleeding was significantly more frequent in duodenal ulcers than in gastric ulcers (11.9% vs 4.0%, p = .004). In a multivariable analysis, rebleeding was significantly related to comorbidity and Forrest classification. Transcatheter angiographic embolization and surgery were required in 6% (34/543) and 0.07% (4/543) of patients, respectively. Complete peptic ulcer healing was found at follow-up in 73.3% (270/368) of patients.
CONCLUSIONS:
Endoscopic hemostasis was achieved in the majority of patients with high-risk ulceration, although the occurrence of rebleeding is a significant challenge, especially in patients with duodenal ulcers. Clinical trial registration: Bleeding Ulcer and Erosions Study (BLUE Study), ClinicalTrials.gov identifier: NCT03367897.
AuthorsKatrine Kauczynska Romstad, Trond Espen Detlie, Taran Søberg, Owen Thomas, Petr Ricanek, Marte Eide Jahnsen, Frode Lerang, Jørgen Jahnsen
JournalScandinavian journal of gastroenterology (Scand J Gastroenterol) Vol. 57 Issue 1 Pg. 8-15 (Jan 2022) ISSN: 1502-7708 [Electronic] England
PMID34663154 (Publication Type: Journal Article)
Topics
  • Endoscopy, Gastrointestinal (adverse effects)
  • Gastrointestinal Hemorrhage (complications, therapy)
  • Hemostasis, Endoscopic (adverse effects)
  • Humans
  • Peptic Ulcer (complications)
  • Peptic Ulcer Hemorrhage (epidemiology, therapy)
  • Recurrence
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: